[Chinese expert consensus on the clinical application of next-generation sequencing technology in myelodysplastic neoplasms (2026)]
{{output}}
Myelodysplastic neoplasms (MDS) are a group of highly heterogeneous myeloid malignancies characterized by cytopenia, dysplasia, and a high risk of leukemic transformation. Next-generation sequencing (NGS) technology enables efficient detection of gene mutation... ...
